Table 3.
Parameter/group | SHAM | OVX | ESTR | SA5 | SA25 |
---|---|---|---|---|---|
AST (U/l) | 39.22 ± 3.38 | 34.72 ± 2.78 | 35.83 ± 3.62 | 38.14 ± 4.08 | 40.35 ± 3.73 |
ALT (U/l) | 23.68 ± 2.19 | 23.52 ± 1.38 | 22.78 ± 1.83 | 23.69 ± 2.08 | 28.38 ± 3.61 |
Uric acid (mg/dl) | 1.13 ± 0.07 | 1.18 ± 0.17 | 1.10 ± 0.10 | 0.86 ± 0.06 | 1.00 ± 0.06 |
Urea (mg/dl) | 25.72 ± 4.74 | 35.36 ± 4.19 | 38.45 ± 5.61 | 32.46 ± 3.63 | 37.49 ± 2.46 |
Creatinine (mg/dl) | 0.449 ± 0.022 | 0.476 ± 0.019 | 0.431 ± 0.035 | 0.472 ± 0.031 | 0.415 ± 0.053 |
Sinapic acid at doses of 5 mg/kg (SA5) and 25 mg/kg (SA25) or estradiol ((ESTR) 0.2 mg/kg) was administered orally to rats, once daily for 28 days. SHAM: sham-operated control rats; OVX: ovariectomized control rats. Results are presented as the mean ± SEM. One-way ANOVA was used for evaluation of statistical significance of the results. No statistically significant differences in results for AST, ALT, uric acid, urea, and creatinine were demonstrated in ANOVA.